Skip to content

Prognostic Value of P30 After Cardiac Arrest

Characteristics of the Somatosensory Evoked Potentials Indicating Poor Neurologic Outcome After Cardiac Arrest

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03175965
Enrollment
88
Registered
2017-06-05
Start date
2017-07-01
Completion date
2018-11-30
Last updated
2019-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Out-Of-Hospital Cardiac Arrest

Keywords

Heart arrest, hypothermia, SEP, prognosis

Brief summary

This study aims to examine whether P30 wave of somatosensory evoked potentials (SEP) is related with outcome after cardiac arrest. The study design is a prospective, multicenter-observational study. Patients survived after out-of-hospital cardiac arrest undergoing hypothermic-targeted temperature management will participate in the study. Relationship of P30 wave of SEP with the neurologic outcome on hospital discharge will be evaluated.

Detailed description

The absence of N20 of the somatosensory evoked potentials (SEP) is recommended as a valuable predictor of poor neurologic outcome in post-cardiac arrest patients. However, interpretation of N20 is affected by the background noise levels. Reliable analysis of N20 is limited with high noise levels and artifacts. Moreover, presence of N20 does not guarantee good neurologic outcome. P30 is a positive deflection of N20 occurring on 25-35 msec. According to our pilot study, N20 without following P30 is related with poor outcome, while N20 followed by P30 is highly related with good outcome. P30 is evident even when the N20 is ambiguous in patients with good outcome. We hypothesized that the negative-positive deflection of N20-P30 components is more valuable predictor than the N20 alone. In this observational study, we will identify whether presence of P30 checked on 24 and 72 hours after cardiac arrest predicts neurologic outcome more accurately than the presence of N20 alone.

Interventions

Somatosensory evoked potential on 24, 72 hours after cardiac arrest.

Sponsors

The Catholic University of Korea
CollaboratorOTHER
Uijeongbu St. Mary Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Comatose survivors after out-of-hospital cardiac arrest

Exclusion criteria

* Not treated by hypothermic-targeted temperature management

Design outcomes

Primary

MeasureTime frameDescription
Association of abscence of P30 with poor outcome without under the influence of hypothermia and sedation72 hours after ROSCSEP under the normothermic-TTM without sedation

Secondary

MeasureTime frameDescription
Association of abscence of P30 with poor outcome under the influence of hypothermia and sedation24 hours after ROSCSEP under the hypothermic-TTM with sedation
Association of N20 with high amplitude with poor outcome without under the influence of hypothermia and sedation72 hours after ROSCSEP under the normothermic-TTM without sedation
Association of N20 with high amplitude with poor outcome under the influence of hypothermia and sedation24 hours after ROSCSEP under the hypothermic-TTM with sedation

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026